
A double mastectomy to beat breast cancer will not improve chances of survival, study reveals
NY Post
The double mastectomy, undertaken by some breast cancer patients as a precautionary measure, provides no advantage to sufferers when it comes to survival, a new study has revealed.
The findings, published this week in JAMA Oncology, are based on analysis of more than 660,000 women diagnosed with breast cancer during the years 2000 and 2019.
Those choosing a double mastectomy — a procedure to remove both breasts, even if only one is affected by the cancer — were shown to have no advantage over those who had a less final lumpectomy, or a mastectomy, People reported.
Women opting for the latter had a 7% chance of finding cancer in the other breast later on.
The two-decade study showed similar death rates in all three groups — 8.5% for lumpectomies, 9% for mastectomies and 8.5% for double mastectomies.
“If you get a contralateral breast cancer, your risk of dying goes up. But preventing it doesn’t improve your survival,” said Dr. Steven Narod at Toronto’s Women’s College Hospital.

The killing of Iran’s tyrannical Supreme Leader Ali Khamenei on Saturday in an unprecedented joint military attack by the US and Israel called Operation Epic Fury set off widespread celebrations from Iranians around the world — as President Trump said it would give them their “greatest chance” to “take back the country.” Meanwhile, in Iran, a lack of internet has made it impossible for Iranians to easily communicate daily conditions. Over a period of three days, with limited VPN connection, an eyewitness currently in Tehran — who, for her safety, is concealing her identity — shared her account of life under a country in the midst of battle with The Post’s Natasha Pearlman.





